
Exagen Inc.
- Home
- Companies
- Exagen Inc.
- Services
- AVISE - Advanced Rheumatology Test

AVISE - Model CTD - Advanced Rheumatology Test
FromExagen Inc.
AVISE CTD is an advanced autoimmune rheumatic disease test specifically designed to aid physicians in the differential diagnosis of systemic lupus erythematosus (SLE). AVISE CTD is the only diagnostic test powered by patented Cell-Bound Complement Activation Products (CB-CAPs), stable biomarkers of complement activation, to help physicians better assess patients with suspected SLE.
Most popular related searches
connective tissue disease
connective tissue
lupus erythematosus
disease testing
clinical utility
rheumatic disease
autoimmune disease
inflammatory disease
patient assessment
autoimmune
There are many clinical scenarios that can benefit from the AVISE CTD test including:
- Assessment of ANA positive referrals
- Patients with clinical suspicion of a connective tissue disease but insufficient criteria for diagnosis
- Assessment of patients with overlapping symptoms
- Observation of Undifferentiated Connective Tissue Disease
- ANA positive fibromyalgia patients with clinical suspicion of underlying autoimmune inflammatory disease